Statins (HMG-CoA reductase inhibitors), cholesterol and stroke

被引：1

作者：

Marta-Moreno, J ^{[1
]}

Echeandia, C ^{[1
]}

Oliveros-Cid, A ^{[1
]}

Figuerola, A ^{[1
]}

Mola, S ^{[1
]}

机构：

[1] Hosp Miguel Servet, Serv Neurol, E-50009 Zaragoza, Spain

来源：

REVISTA DE NEUROLOGIA | 1998年 / 27卷 / 159期

关键词：

cerebral ischemia; cholesterol; HMG-CoA reductase; stroke;

D O I：

10.33588/rn.27159.98262

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

The HMG-CoA reductase inhibitors (known as statins) have been shown to reduce morbi-mortality of vascular origin, including transitory ischemic accidents and cerebral infarcts, in a large group of patients. The implications, both clinical and of costs, oblige us to consider analysis of the existing evidence and the answers to a number of questions arising in a field which has not yet received much attention from neurologists.

引用

页码：827 / 830

页数：4

共 50 条

[21] Various HMG-CoA reductase inhibitors
Thiery, J
Seidel, D
INTERNIST, 1999, 40 (01): : 113 - 114
[22] HMG-CoA reductase inhibitors and the kidney
Vito M. Campese
Bassel Hadaya
Josephine Chiu
Current Hypertension Reports, 2005, 7 : 337 - 342
[23] HMG-CoA reductase inhibitors and apoptosis
Senatore, M
Buemi, M
NEPHRON, 1999, 81 (04): : 439 - 440
[24] Comparing HMG-CoA reductase inhibitors
Jones, PH
CLINICAL CARDIOLOGY, 2003, 26 (01) : I15 - I20
[25] Diplopia and HMG-CoA reductase inhibitors
Fraunfelder, FW
Fraunfelder, FT
Edwards, R
JOURNAL OF TOXICOLOGY-CUTANEOUS AND OCULAR TOXICOLOGY, 1999, 18 (04): : 287 - 289
[26] HMG-COA REDUCTASE INHIBITORS AND SLEEP
SPIELBERG, SP
TOBERT, JA
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 52 (01) : 109 - 110
[27] IMIDAZOLES AS HMG-COA REDUCTASE INHIBITORS
WAREING, JR
LEGINUS, JM
SCALLEN, TJ
LINDER, J
LEE, GT
STABLER, R
MARTIN, M
WIDLER, L
MYERS, SW
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1988, 196 : 106 - MEDI
[28] SYNTHESES OF HMG-COA REDUCTASE INHIBITORS
MIYACHI, N
SUZUKI, M
OHARA, Y
HIYAMA, T
JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN, 1995, 53 (03) : 186 - 196
[29] Syntheses of HMG-CoA reductase inhibitors
Nissan Chemical Industries, Ltd, Chiba, Japan
Yuki Gosei Kagaku Kyokaishi, 3 (186-196):
[30] HMG-CoA reductase inhibitors and myotoxicity
Ucar, M
Mjörndal, T
Dahlqvist, R
DRUG SAFETY, 2000, 22 (06) : 441 - 457

← 1 2 3 4 5 →